Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Anterior uveitis associated with high-dose cytosine arabinoside.

Fintelmann RE, Qian Y, Skalet A, Jeng BH.

Ocul Immunol Inflamm. 2010 Dec;18(6):485-7. doi: 10.3109/09273948.2010.510258. Epub 2010 Oct 1.

PMID:
20887203
2.

Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.

Löwenberg B.

Blood. 2013 Jan 3;121(1):26-8. doi: 10.1182/blood-2012-07-444851. Review.

3.

Toxic epidermal necrolysis after the use of high-dose cytosine arabinoside.

Ozkan A, Apak H, Celkan T, Yüksel L, Yildiz I.

Pediatr Dermatol. 2001 Jan-Feb;18(1):38-40. Review.

PMID:
11207969
4.

Asymmetric anterior uveitis as a delayed complication of treatment with systemic high-dose cytosine-arabinoside: a case report and literature review.

Grewal DS, Holland PM, Frankfurt O, Pyatetsky D.

Ocul Immunol Inflamm. 2014 Aug;22(4):322-5. doi: 10.3109/09273948.2013.801990. Epub 2014 May 15. Review. No abstract available.

PMID:
24832917
5.

High-dose cytosine arabinoside in the treatment of acute myeloid leukaemia.

Cole N, Gibson BE.

Blood Rev. 1997 Mar;11(1):39-45. Review.

PMID:
9218105
6.

[Bases for intravenous administration of cytosine arabinoside in the treatment of adult acute myeloid leukemia].

Thomas X, Archimbaud E.

Bull Cancer. 1995 Nov;82(11):911-22. Review. French.

PMID:
8535017
7.

[Low dose cytarabine in the treatment of acute myeloid leukemia. Apropos of 41 cases].

Frikha M, Elloumi M, Bouaziz M, Daoud J, Mseddi S, Khanfir A, Gargouri J, Souissi T.

Bull Cancer. 1996 Dec;83(12):996-1001. Review. French.

PMID:
9116380
8.

High-dose cytosine arabinoside for the treatment of acute myeloid leukemia. Studies of the North American Marrow Transplant Group.

Wolff SN, Brown RA, Fay JW, Herzig GP, Herzig RH, Phillips GL.

Leukemia. 1992 Nov;6 Suppl 4:71-4. Review. No abstract available.

PMID:
1434839

Supplemental Content

Support Center